Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

656
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
656
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

12.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional pituitary adenoma imaging.

Reviews in endocrine & metabolic disorders·2026
Same author

KCNK16 Deficiency Deteriorates Body Growth and Diet-Independently Decreases Lipid Accumulation in Mice.

Comprehensive Physiology·2026
Same author

Right ventricular free-wall strain-based risk stratification for temporary mechanical circulatory support in cardiogenic shock.

ESC heart failure·2026
Same author

Pituitary adenoma imaging as a determinant of acromegaly diagnosis and outcomes.

The Journal of clinical endocrinology and metabolism·2026
Same author

Real world experience with [<sup>68</sup>Ga]PentixaFor PET/CT in Primary Aldosteronism using newly developed harmonized diagnostic criteria.

Frontiers in endocrinology·2026
Same author

[Need for Improvement in Healthcare Provision for Rare Endocrinological Diseases in Germany Using the Example Endogenous Cushing's Syndrome].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2026

Related Experiment Video

Updated: Nov 3, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.0K

[New Developments in Type 1 Diabetes].

Linus Haberbosch1, Joachim Spranger1

  • 1Klinik für Endokrinologie und Stoffwechselmedizin, Charité-Universitätsmedizin Berlin.

Deutsche Medizinische Wochenschrift (1946)
|June 1, 2021
PubMed
Summary
This summary is machine-generated.

Continuous glucose monitoring (CGM) helps optimize glycemic control in type 1 diabetes. New therapies, including fast-acting insulin and closed-loop systems, alongside emergency glucagon, improve blood sugar management and reduce hypoglycemia risks.

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.0K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.8K

Related Experiment Videos

Last Updated: Nov 3, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.0K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.0K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.8K

Area of Science:

  • Endocrinology and Metabolism
  • Diabetes Mellitus Research
  • Glycemic Control Optimization

Background:

  • Continuous glucose monitoring (CGM) is increasingly vital for managing type 1 diabetes mellitus (T1DM).
  • Optimizing Time in Range (TIR) is linked to reduced cardiovascular events and pregnancy complications.
  • Time below Range (TBR) is crucial for assessing hypoglycemia risk in T1DM.

Purpose of the Study:

  • To review advancements in T1DM management focusing on glycemic control optimization.
  • To highlight new technologies and therapeutic options for T1DM patients.
  • To emphasize the importance of monitoring parameters like TIR and TBR.

Main Methods:

  • Review of recent literature on T1DM management strategies.
  • Analysis of emerging technologies such as CGM, hybrid closed-loop systems, and new insulin formulations.
  • Evaluation of novel therapeutic agents including nasal glucagon and SGLT inhibitors.

Main Results:

  • CGM and TIR monitoring offer significant benefits for T1DM glycemic control.
  • Fast-acting insulin aspart (FIASP) and hybrid closed-loop systems enhance blood glucose management.
  • New emergency therapies like nasal glucagon and complementary therapies like SGLT inhibitors provide additional treatment options.

Conclusions:

  • Modern T1DM management integrates advanced monitoring, innovative insulin therapies, and novel adjunct treatments.
  • Focus on TIR and TBR, alongside new pharmacological and technological tools, leads to improved patient outcomes.
  • Ongoing research and development promise further advancements in T1DM care.